Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
blood test
MedTech
Siemens Healthineers taps ALZpath for Alzheimer's blood test
ALZpath licensed out its pTau-217 antibody, which Siemens Healthineers plans to incorporate in its Atellica immunoassay platforms.
Conor Hale
Dec 16, 2025 2:00pm
Natera buys Foresight Diagnostics in $450M cancer testing deal
Dec 5, 2025 11:57am
Freenome to go public in $330M SPAC deal
Dec 5, 2025 10:35am
FDA approves next-gen PSA test from Cleveland Diagnostics
Dec 3, 2025 10:05am
Grail sees Q3 sales jump, eyes Q1 for FDA Galleri PMA submission
Nov 13, 2025 9:05am
Guardant blood test gives early warning of cancer progression
Nov 10, 2025 8:15am
